ISG20

Last updated

ISG20
Protein ISG20 PDB 1wlj.png
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases ISG20 , CD25, HEM45, interferon stimulated exonuclease gene 20kDa, interferon stimulated exonuclease gene 20
External IDs OMIM: 604533; MGI: 1928895; HomoloGene: 31081; GeneCards: ISG20; OMA:ISG20 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001113527
NM_001291220
NM_001291221
NM_020583

RefSeq (protein)

NP_001106999
NP_001278149
NP_001278150
NP_065608

Location (UCSC) Chr 15: 88.64 – 88.66 Mb Chr 7: 78.56 – 78.57 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Interferon-stimulated gene 20 kDa protein is a protein that in humans is encoded by the ISG20 gene. [5] [6] [7] It belongs to the ISG family of proteins, which are typically stimulated by type I interferon as a response to viral infection.

Contents

Discovery

ISG20 was discovered in 1997 at the Institute for Molecular Genetics (IGMM) within the University of Montpellier. The new protein was discovered through differential display in IFNα/β treated human cells. [8]

Later it was showed that ISG20 expression is driven directly by ssDNA and ssRNA signalling through NF-kB pathways, leading to a more robust expression of ISG20, than through the interferon pathway. [9]

Structure

ISG20 is classified as a member of the DEDDh exonuclease family, defined by a conserved catalytic core consisting of three aspartate residues and one glutamate residue distributed across the Exo I–III motifs, together with an additional conserved histidine residue essential for activity. [10]

Function

ISG20 is an RNA exonuclease, which under normal physiological conditions contributes to the antiviral response of the host [11] . It belongs to the Rex4 exonucleases subfamily and is evolutionarily related to yeast REXO4.

It is enzymatically capable of degrading single-stranded RNA and single-stranded DNA alike. [12]

Clinical significance

ISG20 shows somewhat opposing activity in different types of cancers. While it drives cell proliferation in breast cancer, AML, glioma, cervical cancer, renal cancer, liver cancer and oral cancer, it has been shown to inhibit cell proliferation in ovarian cancer. [13]

While the pathophysiological mechanism is not fully understood, it is thought that in the majority of cases where ISG20 has a proliferative effect, thyroid hormone stimulation causes the secretion of ISG20, which in turn contributes to proliferation, stimulates migration and drives angiogenesis. The proliferative effect is mediated via metalloproteinase MMP-9 pathway by accelerating the G1/S transition, while the stimulation of expression of extracellular matrix degrading enzymes drives migration and invasion. Angiogenesis is mediated by Interleukin 8 and the JAK/STAT Pathway. [14]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000172183 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000039236 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, et al. (August 1997). "Molecular cloning of a new interferon-induced PML nuclear body-associated protein". The Journal of Biological Chemistry. 272 (31): 19457–19463. doi: 10.1074/jbc.272.31.19457 . PMID   9235947.
  6. Mattei MG, Tissot C, Gongora C, Mechti N (Jun 1998). "Assignment of ISG20 encoding a new interferon-induced PML nuclear body-associated protein, to chromosome 15q26 by in situ hybridization". Cytogenetics and Cell Genetics. 79 (3–4): 286–287. doi:10.1159/000134745. PMID   9605874.
  7. "Entrez Gene: ISG20 interferon stimulated exonuclease gene 20kDa".
  8. Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, et al. (August 1997). "Molecular cloning of a new interferon-induced PML nuclear body-associated protein". The Journal of Biological Chemistry. 272 (31): 19457–19463. doi: 10.1074/jbc.272.31.19457 . PMID   9235947.
  9. Espert L, Rey C, Gonzalez L, Degols G, Chelbi-Alix MK, Mechti N, et al. (June 2004). "The exonuclease ISG20 is directly induced by synthetic dsRNA via NF-kappaB and IRF1 activation". Oncogene. 23 (26). Nature: 4636–4640. doi:10.1038/sj.onc.1207586. PMID   15064705.
  10. Zuo Y, Deutscher MP (March 2001). "Exoribonuclease superfamilies: structural analysis and phylogenetic distribution". Nucleic Acids Research. 29 (5). 1017-1026: 1017–1026. doi: 10.1093/nar/29.5.1017 . PMC   56904 . PMID   11222749.
  11. Weiss CM, Trobaugh DW, Sun C, Lucas TM, Diamond MS, Ryman KD, et al. (September 2018). "The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins". mSphere. 3 (5) e00209-18. doi: 10.1128/mSphere.00209-18 . PMC   6147134 . PMID   30232164.
  12. Zheng Z, Wang L, Pan J (February 2017). "Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook". Intractable & Rare Diseases Research. 6 (1): 35–40. doi: 10.5582/irdr.2017.01004 . PMC   5359350 . PMID   28357179.
  13. Zhu X, Jiang S, Zhang L, Zou S, Zhang H, Zhang J, et al. (November 2025). "ISG20: The multifaceted 'molecular star' in cancer research (Review)". Oncology Reports. 54 (5). Spandidos Publications: 1–13. doi: 10.3892/or.2025.8985 . PMC   12452223 . PMID   40937574.
  14. Zhu X, Jiang S, Zhang L, Zou S, Zhang H, Zhang J, et al. (November 2025). "ISG20: The multifaceted 'molecular star' in cancer research (Review)". Oncology Reports. 54 (5). Spandidos Publications: 1–13. doi: 10.3892/or.2025.8985 . PMC   12452223 . PMID   40937574.

Further reading